FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

3862001000001109: Liposomal doxorubicin hydrochloride 50mg/25mL infusion concentrate - product

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2004. Module: SNOMED CT United Kingdom drug extension module

    Descriptions:

    Id Description Lang Type Status Case? Module
    11951101000001112 Liposomal doxorubicin hydrochloride 50mg/25mL infusion concentrate - product en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
    12239901000001110 Liposomal doxorubicin hydrochloride 50mg/25mL infusion concentrate - product en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
    61185501000001118 Liposomal doxorubicin hydrochloride 50mg/25mL infusion concentrate en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Liposomal doxorubicin hydrochloride 50mg/25mL infusion concentrate - product Is a Liposomal doxorubicin hydrochloride 2mg/mL infusion concentrate 25mL vial false Inferred relationship Existential restriction modifier
    Liposomal doxorubicin hydrochloride 50mg/25mL infusion concentrate - product Availability Available only as a proprietary false Additional relationship Existential restriction modifier
    Liposomal doxorubicin hydrochloride 50mg/25mL infusion concentrate - product NHS prescribing status NHS prescribable false Additional relationship Existential restriction modifier
    Liposomal doxorubicin hydrochloride 50mg/25mL infusion concentrate - product Legal category Prescription Only Medicine false Additional relationship Existential restriction modifier
    Liposomal doxorubicin hydrochloride 50mg/25mL infusion concentrate - product CSM recommendation to report adverse reactions Report only serious adverse reactions to the Committee on Safety of Medicines false Additional relationship Existential restriction modifier
    Liposomal doxorubicin hydrochloride 50mg/25mL infusion concentrate - product Product name type Generic name false Additional relationship Existential restriction modifier
    Liposomal doxorubicin hydrochloride 50mg/25mL infusion concentrate - product Has active ingredient Doxorubicin false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Caelyx 50mg/25mL infusion concentrate Is a False Liposomal doxorubicin hydrochloride 50mg/25mL infusion concentrate - product Inferred relationship Existential restriction modifier

    This concept is not in any reference sets

    Back to Start